Chicago Partners Investment Group LLC
Position in ASND — Ascendis Pharma A/S
CIK 1563525
CHICAGO, IL
Position in ASND
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$698,541
-$47,372 QoQ
Shares Held
3,054
-12.7% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#174
of 265 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Chicago Partners Investment Group LLC holds $9,972,920 across 37 Biotechnology names. ASND ranks #4 (7.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,001 | $1,546,052 | |
| 2 | INCY |
Incyte Corp
|
8,174 | $769,336 | |
| 3 | TSHA |
Taysha Gene Therapies, Inc.
|
170,751 | $763,256 | |
| 4 | ASND |
Ascendis Pharma A/S
This page
|
3,054 | $698,541 | |
| 5 | EXEL |
Exelixis, Inc.
|
16,204 | $694,989 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
12,183 | $688,217 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
2,861 | $540,872 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,170 | $522,451 |
All Filings in ASND
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $698,541 | 3,054 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $745,913 | 3,498 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $608,756 | 3,062 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $644,143 | 3,732 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $556,576 | 3,571 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $719,325 | 5,225 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $907,058 | 6,075 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $849,101 | 6,226 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $1,006,641 | 6,659 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $867,291 | 6,886 | Shares | Sole | 2024-02-23 | |
| 2023-09-30 | $828,714 | 8,850 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $650,454 | 7,288 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $823,127 | 7,677 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $936,981 | 7,672 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,028,366 | 9,959 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $731,223 | 7,866 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $913,178 | 7,781 | Shares | Sole | 2022-05-20 | |
| 2021-12-31 | $1,243,864 | 9,246 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $1,444,232 | 9,061 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,219,863 | 9,273 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $1,435,852 | 11,141 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $1,307,388 | 7,839 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $509,564 | 3,302 | Shares | Sole | 2020-11-06 | |
| No filing history on record for this holder in this stock. | ||||||